Mackay Memorial Hospital

Futó vizsgálatok

• Még nem toboroz

  Home Monitor for AA Burden Detection IIT in TWN

  NCT07572279· National Taiwan University Hospital· Forrás

• Toboroz

  A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07881458· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

  NCT07554339· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Még nem toboroz

  Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II

  NCT07134712· 2. fázis· HONYA Medical Co Ltd· Forrás

• Toboroz

  MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

  NCT07431827· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  NCT07318558· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  NCT07227298· 1/2. fázis· Pfizer· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  NCT07216703· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

  NCT07221474· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  NCT07155187· 2/3. fázis· AbbVie· Forrás

• Meghívásos bevonás

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

  NCT07256392· 3. fázis· Celldex Therapeutics· Forrás

• Toboroz

  A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

  NCT07219615· 2. fázis· Pfizer· Forrás

• Toboroz

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Brenipatide in Participants With Alcohol Use Disorder

  NCT07219953· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

  NCT07219966· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

  NCT07190248· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

  NCT07115953· Medtronic Vascular· Forrás

• Még nem toboroz

  Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy

  NCT07151326· 2. fázis· National Health Research Institutes, Taiwan· Forrás

• Fut, nem toboroz

  The Intervention of Lactobacillus Plantarum Probiotics in Adult Autistic Spectrum Disorders

  NCT07118267· Mackay Memorial Hospital· Forrás

• Fut, nem toboroz

  Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits

  NCT07064538· Mackay Memorial Hospital· Forrás

• Fut, nem toboroz

  Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies

  NCT05613621· National Health Research Institutes, Taiwan· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  NCT07062965· 3. fázis· Pfizer· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  NCT07060807· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

  NCT06468033· 3. fázis· PharmaEssentia· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  NCT06966700· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

  NCT06880744· 3. fázis· AbbVie· Forrás

• Toboroz

  Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  NCT06787612· 2. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  NCT06824467· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  NCT06657144· 1. fázis· Coherus Oncology, Inc.· Forrás

• Toboroz

  A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  NCT06841354· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

  NCT06475781· 2. fázis· Foresee Pharmaceuticals Co., Ltd.· Forrás

• Fut, nem toboroz

  Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  NCT06806293· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

  NCT06760637· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

  NCT06699212· 3. fázis· Rakuten Medical, Inc.· Forrás

• Toboroz

  A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  NCT06623422· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  ATTR-CM: A Multi-country, Non-interventional Disease Registry

  NCT06651073· Pfizer· Forrás

• Fut, nem toboroz

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

  NCT06486441· 3. fázis· Gilead Sciences· Forrás

• Toboroz

  Post-Acute Phase of Cardiogenic Shock

  NCT07266675· Mackay Memorial Hospital· Forrás

• Toboroz

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  NCT06226883· 2. fázis· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Forrás

• Fut, nem toboroz

  A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06468228· 3. fázis· AbbVie· Forrás

• Toboroz

  A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  NCT06312176· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  NCT06236438· 2/3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06290934· 2. fázis· Gilead Sciences· Forrás

• Toboroz

  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  NCT06172478· 2. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)

  NCT06938516· A.Menarini Asia-Pacific Holdings Pte Ltd· Forrás

Showing 50 of 84.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák10 toboroz
• Petefészekrák6 toboroz
• Magas vérnyomás4 toboroz
• Áttétes emlőrák3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Chronic spontaneous urticaria2 toboroz
• Crohn-betegség2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Méhnyakrák2 toboroz
• Méhtestrák2 toboroz
• Melanóma2 toboroz
• Tripla negatív emlőrák2 toboroz
• Asztma1 toboroz
• Diabetic foot ulcer1 toboroz
• Elhízás1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus vesebetegség1 toboroz
• Máj- és epeúti rák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pitvarfibrilláció1 toboroz
• Prosztatarák1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan

  NCT06925113· Daiichi Sankyo· Forrás

• Toboroz

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  NCT06717347· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients

  NCT06381986· 2. fázis· Sunhawk Vision Biotech, Inc.· Forrás

• Lezárult

  Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

  NCT06353087· Pfizer· Forrás

• Lezárult

  Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

  NCT06283641· Novo Nordisk A/S· Forrás

• Lezárult

  Quality of Life and Uremic Toxins in HDx

  NCT07936942· Mackay Memorial Hospital· Forrás

• Lezárult

  Precision Diabetes Education Guided by Diabetes Complication Risk Assessment

  NCT07793305· Taiwanese Association of Diabetes Educators· Forrás

• Lezárult

  The Intervention of Psychobiotics in Patients With Anxiety Disorders

  NCT05964231· Mackay Memorial Hospital· Forrás

• Lezárult

  A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05507580· 4. fázis· AbbVie· Forrás

• Lezárult

  OncoSweep Cancer Spotlight and Spectrum Product Line

  NCT06261294· Pharus Taiwan, Inc.· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia

  NCT05606094· Daiichi Sankyo Co., Ltd.· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Leállították

  Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome

  NCT05813899· Mackay Memorial Hospital· Forrás

• Lezárult

  A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

  NCT05642312· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05601882· 3. fázis· AbbVie· Forrás

• Lezárult

  Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)

  NCT05446870· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  Relationship Between Gut Microbiome, Probiotics, and Mild Cognitive Impairment

  NCT04971096· Mackay Memorial Hospital· Forrás

• Lezárult

  A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

  NCT05093933· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

  NCT05007106· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue

  NCT05428527· National Defense Medical Center, Taiwan· Forrás

• Lezárult

  A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001

  NCT04540770· 1. fázis· HuniLife Biotechnology, Inc.· Forrás

• Lezárult

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

  NCT04847557· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

  NCT04697628· 3. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás

• Lezárult

  NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

  NCT04614441· Boehringer Ingelheim· Forrás

• Lezárult

  Effects of Vitamin D Supplementation on Depression and Inflammatory Markers

  NCT04898725· Mackay Memorial Hospital· Forrás

• Lezárult

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

  NCT04533529· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· 3. fázis· Bayer· Forrás

• Lezárult

  A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer

  NCT04300647· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

  NCT04236609· Concept Medical Inc.· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

  NCT04221945· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)

  NCT04199104· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT03904693· 3. fázis· Actelion· Forrás

• Lezárult

  Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

  NCT03976323· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

  NCT03976362· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

  NCT03611712· 2. fázis· PhytoHealth Corporation· Forrás

• Lezárult

  Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)

  NCT03510871· 2. fázis· National Health Research Institutes, Taiwan· Forrás

• Lezárult

  Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

  NCT03740165· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)

  NCT03675737· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· 3. fázis· CSL Behring· Forrás

• Lezárult

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· 3. fázis· Pfizer· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

  NCT03221426· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

  NCT03040999· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)

  NCT03036488· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

  NCT02747004· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Cryo Global Registry

  NCT02752737· Medtronic Cardiac Ablation Solutions· Forrás

Showing 50 of 54.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Fabry-betegség10 munka · 0 vizsgálat
• Familiáris hiperkoleszterinémia4 munka · 0 vizsgálat